methionine has been researched along with Hemangioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, N; Kamada, H; Nishio, A; Takahashi, Y; Yamamoto, D | 1 |
| Asano, Y; Ikegame, Y; Iwama, T; Kawasaki, T; Maruyama, T; Muragaki, Y; Nakayama, N; Nomura, Y; Shinoda, J; Yano, H | 1 |
2 other study(ies) available for methionine and Hemangioblastoma
| Article | Year |
|---|---|
Usefulness of 18F-fluorodeoxyglucose-Positron Emission Tomography in Comparison with Methionine-Positron Emission Tomography in Differentiating Solid Hemangioblastoma from Adult Cerebellar Tumors.
Topics: Aged, 80 and over; Cerebellar Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Hemangioblastoma; Humans; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Characteristics of time-activity curves obtained from dynamic
Topics: Adult; Aged; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Glioma; Hemangioblastoma; Humans; Imaging, Three-Dimensional; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2018 |